Cell & Gene Therapy

eye eyeball retinal diseases
Biotech

J&J gene therapy fails ph. 3 rare eye disease trial

The treatment failed to improve the vision-guided mobility of patients with the eye disease X-linked retinitis pigmentosa.
Darren Incorvaia May 5, 2025 11:33am
AAV virus capsid

Vertex discontinues AAV research for gene therapies

May 2, 2025 6:22pm
Caribou antlers sitting on ground with mountains in background

Caribou cuts 32% of staff, further purges cell therapy pipeline

Apr 24, 2025 9:55pm
Terminated contract

NIH nixes financing for Pluri's radiation exposure cell therapy

Apr 18, 2025 9:10am
roadmap hurdles

Verve posts clean PCSK9 editor profile, teeing up Lilly decision

Apr 14, 2025 7:00am
Biotech year in review - The Top Line

Q1 biopharma layoff trends, plus expectations for Q2

Apr 11, 2025 9:25am
More News

ADCs to cell therapy: How AZ aims to 'redefine' oncology

Apr 9, 2025 11:44am

Lexeo locks in pivotal trial plan as gene therapy data accrue

Apr 7, 2025 9:37am

Lilly saves gene therapy biotech with $18M upfront deal

Apr 3, 2025 6:00pm

Cell therapy biotech bags $102M to fund phase 3 epilepsy plans

Apr 3, 2025 1:22pm